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endothelial dysfunction is recognized as a major contributor to atherosclerosis and has been 
suggested to be evident far before plaque formation. Endothelial dysfunction in small resistance 
arteries has been suggested to initiate long before changes in conduit arteries. In this study, we 
address early changes in endothelial function of atherosclerosis prone rats. Male ApoE knockout (KO) 
rats (11- to 13-weeks-old) were subjected to either a Western or standard diet. The diet intervention 
continued for a period of 20–24 weeks. Endothelial function of pulmonary and mesenteric arteries 
was examined in vitro using an isometric myograph. We found that Western diet decreased the 
contribution of cyclooxygenase (COX) to control the vascular tone of both pulmonary and mesenteric 
arteries. These changes were associated with early stage atherosclerosis and elevated level of plasma 
total cholesterol, LDL and triglyceride in ApoE KO rats. Chondroid-transformed smooth muscle cells, 
calcifications, macrophages accumulation and foam cells were also observed in the aortic arch from 
ApoE KO rats fed Western diet. The ApoE KO rats are a new model to study endothelial dysfunction 
during the earlier stages of atherosclerosis and could help us improve preclinical drug development.
Cardiovascular disease is the leading cause of death  globally1. Endothelial dysfunction is known to play a central 
role in the progression of cardiovascular disease and changes in endothelial function are reported to occur prior 
to the development of atherosclerotic  plaques2–4.
Atherosclerosis is a chronic inflammatory  disease5–7. In its early phases, it is associated with dyslipidemia, 
increased expression of inflammatory factors and endothelial  dysfunction8,9. At later stages, atherosclerotic 
lesions develop in conduit  arteries9. The aorta and its major branches constitute the classical sites of athero-
sclerotic lesions. Endothelial dysfunction in small resistance arteries has been suggested to initiate long before 
changes in conduit  arteries10–12. Therefore, understanding the mechanisms that trigger early endothelial dysfunc-
tion in resistance arteries are essential for our understanding of the early stages of atherosclerosis pathology, and 
consequently, early diagnosis and prevention. However, there are few reports of atherosclerotic plaques in other 
arteries such as the pulmonary  artery13,14.
Laboratory animals are widely used to study endothelial dysfunction in cardiovascular disease, however, 
none of the current models reproduce human pathology in detail and there is no optimal  model15. It has been 
shown that dyslipidemia itself does not cause atherosclerotic changes in  rats16. Mice and rats do not normally 
develop atherosclerosis, but genetic modifications have been shown to facilitate its  development15. Apolipopro-
tein knockout (ApoE KO) mice have been widely used to study atherosclerosis pathology and  treatment15. ApoE 
plays an important role in cholesterol transport and metabolism by facilitating the removal of very low density 
lipoprotein (VLDL)  remnants17. Elevated VLDL, LDL and triglycerides cause dyslipidemia, which is linked 
to development of oxidative stress and  atherosclerosis18. However, experimental atherosclerosis development 
in mice is different from that in humans. In contrast to ApoE KO mice, which rapidly develop atherosclerosis 
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when fed a high-fat diet, humans develop atherosclerosis slowly over the course of months or  years15,19. With the 
development of genome editing technology, ApoE KO rats are now available and several studies have showed 
that atherosclerotic lesions develop slower in rats than in  mice20,21. There is an ongoing discussion about the 
amount of lesion development in ApoE KO rats, and it appears that the location of targeted genomic change 
might influence the development of  lesions22,23. To date, there are no comprehensive reports that characterise 
the vascular properties of ApoE KO rats.
Therefore, in this study, we examined the vascular phenotype of small (so-called, resistance) pulmonary 
and mesenteric arteries in ApoE KO rats fed a high-fat Western diet. Our aim was to assess the development of 
endothelial dysfunction in these small arteries and the mechanisms that promote atherosclerosis development.
Results
The body weight was similar in all groups before starting the diet intervention at the age of 11–13- weeks-old. At 
the end of the study, at the age of 31–37 weeks; body weight increased significantly in all groups; (661.0 ± 55.40 g) 
in ApoE KO on Western diet, (586.30 ± 67.69 g) in ApoE KO on standard diet and (574.0 ± 10.77 g) in the Sprague 
Dawley rats on standard diet (P < 0.0001). The increase in weight was greater in ApoE KO on a Western diet and 
there was a significant difference in body weight between this group and ApoE KO and Sprague Dawley rats on 
a standard diet (P = 0.0005).
Plasma total cholesterol, LDL and triglyceride was elevated in ApoE KO rats fed on a Western 
diet. The plasma cholesterol level was significantly higher in ApoE KOs compared to Sprague Dawley rats 
before the onset of the different diets (Fig. 1; Table 1, P < 0.0001, n = 15). After 5 months of diet, plasma choles-
terol was significantly increased in ApoE KO rats on Western diet and Sprague Dawley rats on standard diet but 
not in ApoE KOs on standard diet. The effect was striking for ApoE KO rats on the Western diet, where choles-
Figure 1.  Monthly plasma cholesterol, LDL and HDL level and fasted triglyceride level vs diets in ApoE KO 
and Sprague Dawley rats. Cholesterol and LDL levels were significantly higher before the start of diet in ApoE 
KO rats compared to the Sprague Dawleys rats, (**) P < 0.0001; After 5 months of diet, cholesterol, LDL and 
triglyceride levels were significantly higher in ApoE KO rats fed on western diet compared to the ApoE KO and 
Sprague Dawley rats on standard diet, (**) P < 0.0001; HDL level was significantly higher in Sprague Dawley rats 
before and after control diet compared to the ApoE KO rats, (**) P < 0.0001; ANOVA, n = 8, n = 7.
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terol levels increased > ten-fold compared to Sprague Dawley rats on standard diet (Fig. 1; Table 1, P < 0.0001, 
n = 8). For ApoE KOs on standard diet, the cholesterol level was still doubled compared to Sprague Dawley rats 
on standard diet (Fig. 1; Table 1, P = 0.0004, n = 7).
Before diet commencement, ApoE KOs had significantly higher plasma LDL levels compared to Sprague 
Dawley rats (Fig. 1; Table 1, P < 0.0001). Plasma LDL increased significantly in ApoE KOs after 5 months on 
either Western (Fig. 1; Table 1, P < 0.0001, n = 8) or standard diet (Fig. 1; Table 1, P = 0.0009, n = 7). Plasma LDL 
also significantly increased in Sprague Dawley rats on standard diet (Fig. 1; Table 1, n = 8). However, the plasma 
LDL level was significantly higher in ApoE KO rats on Western diet compared to ApoE KO and Sprague Dawley 
rats on standard diet (Fig. 1; Table 1, P < 0.0001).
Triglyceride levels were measured after 5 months of diet; levels were significantly higher in ApoE KOs on 
Western diet compared to ApoE KO and Sprague Dawley rats on standard diet (Fig. 1; Table 1, P < 0.0001).
On the other hand, plasma HDL levels were significantly higher in Sprague Dawley rats compared to ApoE 
KOs before the diet started (Fig. 1; Table 1, P < 0.0001). Plasma HDL levels significantly increased in all groups 
after 5 months of diet, however, it was still significantly higher in Sprague Dawley rats (Fig. 1; Table 1, n = 8) 
compared to the ApoE KOs on Western (Fig. 1; Table 1, P < 0.0001, n = 8) or standard diet (Fig. 1; Table1, P = 0.01, 
n = 7).
immunohistochemistry. The results from H & E staining showed chondroid-transformed smooth muscle 
cells and calcifications in ApoE KO rats fed on the Western diet, which revealed common features of atheroscle-
rotic lesions (Fig. 2A). No changes were observed in Sprague Dawley rats (Fig. 2B). Further staining with CD-68 
revealed accumulation of macrophages and small foam cell lesions only in ApoE KO fed Western diet (Fig. 2C).
Table 1.  Summary of lipoprotein levels over time. Data presented as mean ± SD; ApoE KO: ApoE knockout.
Total cholesterol (mmol/L)
ApoE KO western diet ApoE KO standard diet Sprague Dawley standard diet
Baseline 6.53 ± 1.75 6.32 ± 0.79 1.89 ± 0.24
Following 5 months diet 36.43 ± 9.10 6.30 ± 1.80 3.14 ± 0.54
LDL (mmol/L)
Baseline 1.30 ± 0.47 1.44 ± 0.46 0.23 ± 0.07
Following 5 months diet 30.20 ± 5.69 3.94 ± 1.42 0.71 ± 0.22
Triglyceride (mmol/L)
Following 5 months diet 4.82 ± 3.83 1.68 ± 0.47 2.20 ± 0.53
HDL (mmol/L)
Baseline 0.51 ± 0.15 0.59 ± 0.17 1.56 ± 0.22
Following 5 months diet 1.51 ± 0.21 0.92 ± 0.23 2.06 ± 0.30
Figure 2.  Microscopic images of the aortic arch from ApoE KO rat fed Western diet; (A) H & E staining at 
60 × magnification showed chondroid-transformed smooth muscle cells; (B) H & E staining in Sprague Dawley 
rat; (C) CD-68 staining revealed accumulation of macrophages and small foam cell lesions.
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COX-dependent signaling was modified in pulmonary arteries from ApoE KO rats fed on a 
Western diet. Vessel contraction was expressed relative to the maximal contraction of KPSS (100% of con-
traction). There were no differences in contractile responses to KPSS between the experimental groups (Supple-
mentary fig. S3A). Contractile responses of pulmonary arteries to increasing concentrations of the thromboxane 
 A2 receptor agonist, U46619, were similar in all groups under control conditions. (Fig. 3).
The contraction response was significantly potentiated in all experimental groups in the presence of L-NAME 
(Fig. 3; P < 0.0001). The difference between the contractile response was not different between the groups (Sup-
plementary fig. S4B).
In pulmonary arteries of ApoE KO-Western diet rats, contractile responses to U46619 were significantly 
potentiated by pre-incubation with both L-NAME and indomethacin (Fig. 3, Table 2, P = 0.01). However, pre-
incubation with L-NAME and indomethacin reduced the contractile responses to U46619 in ApoE KO-standard 
diet and Sprague Dawley rats (Fig. 3, Table 2, P = 0.007 and 0.002, respectively). In the presence of indomethacin, 
the U46619 contractions were significantly different between ApoE KO-Western diet and either ApoE KO or 
Sprague Dawley rats on standard diet (Supplementary fig. S4C, P < 0.0001), suggesting that net COX activity in 
pulmonary arteries from ApoE KO-Western diet rats contributed to production of vasorelaxing factors while it 
had pro-contractile action in arteries from ApoE KO-standard diet or Sprague Dawley rats.
After pharmacological inhibition of all major pathways for endothelium-dependent relaxation, i.e. pre-
incubation with L-NAME, indomethacin, TRAM-34 and apamin, no further significant change in U46619 
induced contraction was observed (Fig. 3, Table 2), suggesting that there was no significant contribution of the 
endothelium-dependent hyperpolarizing (EDH) component to the control of wall tension in these arteries under 
these experimental conditions (Supplementary fig. S4D, Table 2, P < 0.0001).
Figure 3.  U46619 concentration–response curves of pulmonary arteries from different experimental groups 
under different experimental conditions; control conditions, incubation for 20 min with non-selective inhibitor 
of NO synthase, L-NAME (100 µM), incubation for 20 min with both L-NAME (100 µM) and indomethacin 
(3 µM); 20 min incubation with Cocktail: L-NAME, indomethacin, TRAM-34 and apamin, i.e. pharmacological 
inhibition of all major pathways for endothelium-dependent relaxation; (**), P < 0.001, effect of L-NAME; (+ +), 
P = 0.007, effect of indomethacin, F test, n = 8, 7.
Table 2.  Summary of logEC50 ± SE in pulmonary arteries in response to U46619 and mesenteric arteries 
to ACh in control situation; 20 min incubation  with L-NAME; 20 min  incubation with LNAME and 
indomethacin; 20 min incubation with with cocktail: L-NAME, indomethacin, TRAM-34 and apamin;  Emax, 
maximum contractile response;  Rmax, maximum relaxation response.
Incubation with
ApoE KO-western diet ApoE KO- standard diet Sprague Dawley
n = 8 n = 7 n = 8
−logEC50 ± SEM Emax ± SEM −logEC50 ± SEM Emax ± SEM −logEC50 ± SEM Emax ± SEM
Pulmonary artery
Control situation 7.06 ± 0.15 83.34 ± 9.01 6.92 ± 0.11 97.64 ± 7.73 6.78 ± 0.15 95.90 ± 10.22
L-NAME 7.08 ± 0.12 141.3 ± 10.61 7.2 ± 0.13 145.2 ± 10.91 7.07 ± 0.13 141.0 ± 11.54
L-NAME + indomethacin 7.36 ± 0.10 145.7 ± 8.29 7.05 ± 0.12 126.0 ± 9.74 6.77 ± 0.21 121.3 ± 15.90
Cocktail 7.33 ± 0.08 141.3 ± 7.33 7.16 ± 0.19 121.8 ± 8.18 6.83 ± 0.18 110.8 ± 12.50
−logEC50 ± SEM Rmax ± SEM −logEC50 ± SEM Rmax ± SEM −logEC50 ± SEM Rmax ± SEM
Mesenteric artery
Control situation 6.89 ± 0.15 59.61 ± 4.70 6.96 ± 0.12 61.81 ± 3.51 7.16 ± 0.11 59.28 ± 3.47
L-NAME 6.54 ± 0.57 20.42 ± 2.92 7.12 ± 0.26 18.90 ± 1.94 6.08 ± 0.62 48.40 ± 12.84
L-NAME + indomethacin 6.95 ± 0.83 27.78 ± 4.48 7.75 ± 0.28 27.37 ± 2.80 7.29 ± 0.22 32.70 ± 3.00
Cocktail 8.045 ± 0.22 18.21 ± 1.51 7.58 ± 0.10 18.87 ± 0.82 7.39 ± 0.13 15.99 ± 0.90
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Vessel relaxation was expressed as percentage of the pre-constricted level (0% relaxation) to passive wall ten-
sion (100% relaxation). Pre-constricted pulmonary arteries were compared also for their ACh-induced relaxation 
responses under control conditions. A high concentration of ACh  (10-5 M) caused greater relaxation in pulmo-
nary arteries from ApoE KO rats on a Western diet compared to that of a standard diet (Fig. 4A; 38.58 ± 7.75 
vs 15.34 ± 5.20, P = 0.03, n = 8 and 7). However, ACh-induced relaxation was not significantly different between 
pulmonary arteries of Sprague Dawley rats and ApoE rats on either diet (Fig. 4A).
Relaxation was significantly suppressed in all groups after 20 min incubation with L-NAME (Fig. 4B, 
P < 0.001). However, the significant difference between ApoE KO-Western diet and ApoE KO-standard diet 
remained (Fig. 4B, 38.58 ± 7.75 vs 42.39 ± 8.46, P = 0.0002, n = 8, 7).
After adding indomethacin and L-NAME there was no relaxation in responses to ACh in any group (Fig. 4C). 
When all major pathways for endothelium-dependent relaxation were blocked with L-NAME, indomethacin, 
TRAM-34 and apamin, the relaxation was abolished in pulmonary arteries of all groups (Fig. 4D). This further 
supports the lack of significant contribution of the EDH signaling in these pulmonary arteries under these 
experimental conditions.
When endothelial-independent relaxation was tested by sodium nitroprusside (SNP), there was a significant 
difference between the responses of arteries from ApoE KO-Western diet and either Sprague Dawley rats or 
ApoE KO-standard diet (Fig. 5A).
NO was a major contributor to relaxation of the mesentery arteries in all groups. There were 
no differences in contractile responses to KPSS in mesenteric arteries between the experimental groups (Sup-
plementary fig. S3B). Contractile responses to NA in mesenteric arteries from Sprague Dawley rats were signifi-
cantly larger than in the ApoE KO-Western diet group (Fig. 6, P = 0.01).
There were no differences in ACh-induced relaxation between experimental groups under control condi-
tions (Supplementary fig. S5A). Incubation with L-NAME significantly suppressed the relaxation in all groups. 
This suppression was larger in both groups of ApoE KO rats compared to Sprague Dawley rats (Fig. 7, Table 2, 
P < 0.001), suggesting a greater contribution of NO to endothelium-dependent relaxation in mesenteric arteries 
from ApoE KO rats.
Incubation with indomethacin (in the presence of L-NAME) did not affected the relaxation in the ApoE KO-
Western diet group (Fig. 7). This was however significantly improved in the ApoE KO-standard diet group (Fig. 7, 
P < 0.001). There was also a strong tendency for improvement (Fig. 7, P < 0.07) in mesenteric small arteries from 
Sprague Dawley rats. This suggests that in ApoE KO-standard diet and Sprague Dawley groups, product(s) of 
COX activity had pro-contractile effect under these experimental conditions. In the presence of L-NAME and 
indomethacin, no difference in ACh-induced relaxations between the groups was seen (Supplementary fig. S5C).
Figure 4.  Percentage of relaxation in pulmonary arteries in response to 10–5 M concentration of ACh under 
different experimental conditions; (A) control conditions, (**), p < 0.01, ApoE KO-western diet vs ApoE 
KO-control diet; (B) incubation for 20 min with non-selective inhibitor of NO synthase, 100 µML-NAME, (**), 
p < 0.001, ApoE KO-Western diet vs ApoE KO-standard diet; (C) incubation for 20 min with both L-NAME and 
3 µM indomethacin, (**), p < 0.001, ApoE KO-standard diet vs Sprague Dawley ; (D) 20 min incubation with 
Cocktail: L-NAME, indomethacin, TRAM-34 and apamin, i.e. pharmacological inhibition of all major pathways 
for endothelium-dependent relaxation. ANOVA, n = 8, 7.
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After pre-incubation with L-NAME, indomethacin, apamin and TRAM-34, there was significant suppression 
of relaxation responses in all groups (Fig. 7, Table 2, P < 0.001), suggesting a contribution of EDH signaling. The 
effect of incubation with all inhibitors was slightly but significantly different between ApoE KOs and Sprague 
Dawley rats on standard diet (Supplementary fig. S5, P < 0.002).
Endothelium-independent relaxation was tested by SNP. There was a significant difference in relaxation 
responses between Sprague Dawley rats and either, ApoE KO-Western diet rats (Fig. 5B; −logEC50, 7.86 ± 0.16 
Figure 5.  SNP concentration–response curves of (A) pulmonary arteries, (**), p = 0.03, ApoE KO Western diet 
vs Sprague Dawley, (+ +), P = 0.0002, ApoE KO Western diet vs ApoE KO-standard diet; (B) mesenteric arteries, 
(**), P = 0.02, ApoE KO Western diet vs Sprague Dawley, (xx), P = 0.0003, ApoE KO-standard diet vs Sprague 
Dawley; n = 8, 7.
Figure 6.  Concentration–response curves to noradrenaline of mesenteric arteries. (***), P < 0.05 ApoE KO 
Western diet vs Sprague Dawley rats. n = 8, n = 7.
Figure 7.  ACh concentration–response curves of mesenteric arteries from different experimental groups 
under; control conditions; after 20 min incubation with non-selective inhibitor of NO synthase, L-NAME 
(100 µM); after the incubation with both L-NAME (100 µM) and indomethacin (3 µM); after 20 min incubation 
with Cocktail: L-NAME, indomethacin, TRAM-34 and apamin, i.e. pharmacological inhibition of all major 
pathways for endothelium-dependent relaxation; (**), P < 0.001, effect of L-NAME; (+ +), P < 0.001, effect of 
indomethacin, (xx), P < 0.001, effect of Cocktail, n = 8, n = 7.
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vs 7.97 ± 0.05, p = 0.02, n = 8) or ApoE KO-standard diet rats (Fig. 5B; −logEC50, 8.05 ± 0.06 p = 0.0003, n = 7). 
These results confirm our finding of increased sensitivity of smooth muscle cells to NO in arteries of ApoE KOs.
No detectable changes in cyclooxygenase protein expression. Our functional study suggested 
that the Western diet modified cyclooxygenase (COX)-dependent signaling in the pulmonary artery of ApoE 
KO rats. However, we found no difference in COX-1 and COX-2 protein expression between the groups (Sup-
plementary fig. S6).
Discussion
This is the first study addressing endothelial function in arteries from ApoE KO rats fed a Western diet. The 
main finding was that endothelial dysfunction in male ApoE KOs on a Western diet was associated with changes 
in COX-dependent signaling in pulmonary arteries despite no detectable changes in the protein expression of 
COX-1 and -2. Moreover, we found that smooth muscle cells in mesenteric arteries of ApoE KOs were more 
sensitive to NO, and suggest that this might be a compensation for oxidative stress-reduced NO bioavailability 
resulting from hypercholesteremia. Accordingly, ApoE KO rats had significantly higher levels of plasma choles-
terol, LDL and triglycerides compared to the other experimental groups. We also observed early atherosclerotic 
lesions, such as small foam cell lesions and accumulation of macrophages, in the aortic arch of ApoE KO rats 
on Western diet.
Endothelium-dependent relaxation has been reported to be impaired in atherosclerotic arteries in humans 
and experimental animals even before atherosclerotic lesions appear; more severely in males than in females 
pre-menopausal24. However, this sex-dependent effect in rodents is still under debate; some studies have reported 
that females are more susceptible, while others have reported that males are more  susceptible25,26. In CRISPR/
Cas9-generated ApoE KO rats, males developed more severe atherosclerosis than  females23. In this current study 
we did not aim to understand the sex differences in atherosclerosis development in ApoE KO rats and therefore 
studied only males.
Small resistance arteries are affected by dyslipidemia and contribute to increases in vascular  resistance11,12. 
These arteries develop endothelial dysfunction prior to atherosclerotic changes in large  arteries11,12. In the healthy 
endothelium, there is a balance between vasodilator and vasoconstrictor substances, and any imbalance leads 
to endothelial  dysfunction27. The endothelium produces vasodilator substances such as NO, prostaglandins 
(PGs), prostacyclin and EDH, as well as vasoconstrictor substances such as superoxide anion  O2-, endothelin-1 
(ET-1) and thromboxane  A228,29. The balance between these factors defines the final endothelium contribution 
to vascular tone.
Reduced NO bioavailability is recognized as a key factor for endothelium-dependent relaxation dysfunction 
in rabbits and ApoE/LDL receptor-knockout mice fed a high fat  diet24,30. NO is the most important vasodila-
tor in both resistance and large  arteries10. Increased reactive oxygen species (ROS), especially  O2- as a result of 
hypercholesterolemia, could affect the bioavailability of  NO31–33. To investigate the role of NO in endothelium-
dependent relaxation, we incubated pulmonary arteries with L-NAME (non-selective inhibitor of NO synthase). 
However, no differences in L-NAME effect on ACh-induced relaxation or U46619-induced contraction between 
ApoE KOs on Western diet and ApoE KOs or Sprague Dawley rats on standard diet were observed. The role of 
hypocholesteremia in excess ROS production and oxidative stress has been shown  before33. In a previous study 
on ApoE KO rats, we observed no increase in oxidative stress in the pulmonary artery of ApoE KO rats when 
assessed by lipid peroxidation in plasma. Moreover, we found that Tempol, a superoxide scavenger, did not affect 
endothelium-dependent  relaxation34. However, in the previous study the rats were younger (6–9 weeks old) and 
fed a standard diet while in the current study, ApoE KO rats were fed a Western diet and developed significant 
hypercholesterolemia. However, the L-NAME sensitive component of endothelium-dependent relaxation was still 
unchanged. In this term, it is surprising that the sensitivity to NO assessed with the endothelium-independent 
SNP relaxation was increased in ApoE KO rats on the Western diet. We suggest therefore that NO bioavail-
ability might be reduced in pulmonary arteries from these ApoE KO rats on Western diet, possibly because of 
dyslipidaemia-induced oxidative stress, which may have been compensated by increased sensitivity of smooth 
muscle cells to NO. Further studies with direct measurements of NO and cGMP-dependent signaling in smooth 
muscles are necessary to clarify this possibility.
In cardiovascular disease associated with atherosclerosis, there is a shift in the balance of the different 
endothelium-derived factors. Importantly, there is increased production of endothelium-derived contractile 
factors; this occurs independently of reduced NO production or availability and is also associated with increased 
oxidative  stress35,36. Oxidative stress has been shown to trigger endothelium-derived contraction by upregulation 
of COX-1 and/or the induction of COX-210,37. In this study, we found no relaxation in ApoE KO-Western diet 
rats after incubation of the pulmonary artery with both L-NAME and indomethacin, a non-selective inhibitor of 
COX enzymes. This is in accordance to previous findings in renal arteries of male Wistar-Kyoto rats, suggesting 
the key importance of NO and COX associated pathways of endothelium-dependent  relaxation38. We did not, 
however, observe any changes in protein expression of COX-1 and COX-2 in ApoE KOs, either on Western or 
standard diet, therefore the COX-dependent contraction was apparently not related to expressional changes of 
COXs enzymes but is possibly due to changes in the activity of downstream enzymes or receptor distribution.
COX1 and COX2 are important in the regulation of vascular tone. These enzymes are involved in the forma-
tion of prostanoids such as prostacyclin  (PGI2), a vasorelaxant factor, and thromboxane A2, isoprostanes and 
 PGH2, which are  vasoconstrictors38–40. There is a balance between these COX products under normal conditions, 
but this can change with aging or  disease10. Pro-contractile prostanoids and thromboxane A2 are increased in 
atherosclerosis and account for most of the endothelium-mediated  contraction39,41. COX-1 is the main source 
of thromboxane A2 and COX-1 deletion prevents atherosclerotic lesion formation in ApoE null  mice39. On 
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the other hand, aging and hypertension suppresses prostacyclin-induced arterial  relaxation27,35,41. Studies of 
spontaneously hypertensive rats (SHR) and WKY rats have shown that ACh causes a considerable release of 
prostacyclin. However, the ability of prostacyclin to induce relaxation decreases in aged and hypertensive rats; 
instead it elicits  contraction35. This can explain the results of the present study, where despite of unchanged COX 
expression, we observed functional changes of indomethacin that were different between the groups. Our find-
ings suggest that small arteries from ApoE KO rats develop endothelial dysfunction prior to the development of 
atherosclerotic  lesions39,41. Interestingly, our study shows that in rat pulmonary arteries, COX activity produced 
pro-contractile net-effect in Sprague Dawley rats and ApoE KO rats fed the standard diet, while vasorelaxing 
COX action was only seen in ApoE KO rats fed a Western diet. Whether this is an adaptive change, for example 
for putative reduction in NO bioavailability or production as discussed above, or a result of pathological devel-
opment due to hypercholesterolemia remains to be shown. Importantly, U46619 is a thromboxane  A2 agonist 
and this can further complicate the results.
The responses of mesenteric arteries from ApoE KO and Sprague Dawley rats were different from that of the 
pulmonary arteries. Given that L-NAME strongly suppressed ACh-induced relaxation, it could be concluded that 
NO had a significant role in endothelium-dependent relaxation in ApoE KO mesenteric arteries, irrespective of 
diet. It was previously shown that NO-mediated endothelium-dependent relaxation is impaired in ApoE KO mice 
fed a Western diet due to increased  O2-  production33. Similar results were observed in aorta of 32–35 months-
old Sprague Dawley rats despite increased NO synthase expression and increased activity of the l-arginine/NO 
 pathway42. In atherosclerosis prone arteries, the increased  O2- has a significant role in deactivating NO and form-
ing  peroxynitrite33,42. This seems to be the case in our study. Stronger suppression of endothelium-dependent 
relaxation of mesenteric arteries from ApoE KO rats in the presence of L-NAME suggests larger NO signaling 
that might be a mechanism to compensate the increased production of  O2- as a result of hypercholesteremia. 
Since we did not directly measure NO production and its bioavailability, we cannot specify the changes in NO 
signaling. However, an increased NO sensitivity seen in the experiment with SNP suggests that this potentiation 
of NO signaling might be at the level of smooth muscle cells.
A small effect was observed after inhibition of both COX and EDH signaling in mesentery arteries from 
ApoE KO rats on Western diet. This suggests that EDH signaling was suppressed in this experimental group in 
comparison with Sprague Dawley rats. This is in accordance with previous observations in mesenteric arteries 
of diabetic  rats43. In contrast, COX inhibition slightly improved the relaxation of the arteries from ApoE KO rats 
on the standard diet, suggesting some pro-contractile action of COX products in these arteries. EDH inhibition 
suppressed this relaxation, indicating that some vasorelaxing EDH effect was present in the mesenteric arteries 
from ApoE KO rats on the standard diet but was suppressed after exposure to the Western diet. However, the 
contribution of EDH signaling was clearly reduced in ApoE KO rats on any diet in comparison with Sprague 
Dawley rats, although Sprague Dawley rats did not show any significant COX-dependent response. This is in 
accordance with previous reports suggesting that COX signaling is not significant for rat mesenteric arteries 
under normal  condition44. Thus, mesenteric arteries from ApoE KO rats show an increased contribution of NO 
in comparison with Sprague Dawley rats, and this is balanced by an increased pro-contractile action of COX 
products in ApoE KO rats on the standard diet and by diminished EDH signaling in those on the Western diet.
Though providing highly standardized experimental conditions, pharmacological studies of endothelial func-
tion using the isometric myograph has significant limitations. We used ACh to induce endothelium-dependent 
responses, while in in vivo conditions endothelium-dependent factors modulate vascular tone under influence of 
blood flow changes and numerous humoral factors. We do not know whether hemodynamic parameters in vivo 
were different between the groups of rats. It is also possible that dyslipidaemia and associated inflammation could 
contribute to the endothelial state in ApoE KO rats in vivo while these humoral factors were not present in the 
myograph. These uncertainties should be considered in future studies. In the present study, only ApoE KO rats 
were fed the Western diet. However, this diet itself has been shown to induce the formation of reactive oxygen 
species and  inflammation45,46, although this is not in agreement with other  studies16. It is therefore possible that 
some Western diet associated changes observed in our ApoE KO rats, would also be seen in Sprague Dawley 
rats if they were fed the same diet. This was however out of the scope of our study into whether Western diet can 
accelerate endothelial dysfunction and earlier atherosclerosis in ApoE KO rats specifically.
conclusion
To our knowledge this is the first report examining the vascular phenotype in ApoE KO rats fed a Western diet. 
The results are in accordance with previous data on atherosclerosis obtained in other models of atherosclerosis, 
in which changes in COX contribution to vascular tone is associated with endothelial dysfunction at early stage 
of atherosclerosis and the significant role of oxidative  stress32,41,42. An animal model for atherosclerosis that bet-
ter mimics the time course of the disease in humans will improve our understanding of the therapeutic utility 
of COX  inhibitors40,47. The ApoE KO rats are a new model to study endothelial dysfunction during the earlier 
stages of atherosclerosis and could help us improve preclinical drug development.
Methods
A summary chart of the study design is shown in supplementary fig. S1.
Animals. 15 male ApoE KO and 8 male Sprague Dawley rats aged 11 to 13 weeks old were used (Horizon 
Discovery, Saint Louis, USA). The Zinc Finger (ZF) technique was used by Horizon Discovery to produce the 
ApoE KO rats. Animals were housed 2 per cage (temperature 21 ± 1 °C, 12–12 h light–dark cycle). ApoE KO 
rats were randomly subjected to either a Western diet (weight 360.10 ± 8.39 g, n = 8) or a standard diet (weight 
352.10 ± 7.94  g, n = 7), where 41% and 10% of the energy comes from fat, respectively (Cat. #D12079B and 
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Cat. #D 98,121,701, Brogaarden Korn & Foder ApS, Lynge, Denmark). Sprague Dawley rats were included as a 
genetic background  control22 and fed the standard diet (weight, 373.9 ± 7.69, n = 8). All animals had ad libitum 
access to food and water. The project continued for 20–24 weeks. After 20–24 weeks of Western or standard diet, 
rats were anesthetized with Sevofloran (Sevorane, AbbVie, Copenhagen, Denmark) and euthanized by decapita-
tion at age of 31–37 weeks old.
isometric force measurement. The pulmonary artery (first bronchial artery in right lobe) and third order 
mesenteric were dissected and mounted in an isometric myograph (Danish Myo Technology, Aarhus, Denmark) 
as described  previously34. Maximal contractile response was assessed with potassium solution (KPSS): equi-
molar substitution of KCl for NaCl in PSS. Contractility of pulmonary and mesenteric arteries were tested by 
cumulative applications of the thromboxane  A2 receptor agonist, U46619  (10−8–3×10−6 M), and noradrenaline 
(NA,  10−8–3×10−5 M). Endothelial function was assessed by relaxing pre-constricted arteries with acetylcholine 
(ACh:  10–7,  10–6 and  10–5 M). Pre-constrictions to approximately 70% of the KPSS-induced maximal constric-
tion were obtained with either U46619 or NA-mediated stimulations of the pulmonary and mesenteric arteries, 
respectively. No time effect was observed in separate time-control experiments (Supplementary fig. S2).
Blood sampling and tissue collection. Blood samples from the tail vein were collected in 500 ul EDTA 
tubes (Microvette 500 K3E, Hounisen, Skanderborg, Denmark) monthly from the onset of the diet while the 
rats were under sevoflurane anesthesia. The last sample was collected from the left heart ventricle in 4 mL EDTA 
vacutainer tubes immediately following anesthesia after the rats had fasted overnight. All blood samples were 
centrifuged at 4.000 g for 10 min at 4 °C within 30 min of collection. Aspirated plasma was stored at − 80 °C until 
assayed. The rest of the pulmonary arteries that did not go into the functional studies were dissected and snap-
frozen in liquid  N2 and stored at − 80 °C until analysis.
immunohistochemistry. The aortic arch and thoracic aorta were isolated and fixed in 4% PFA (Para-
formaldehyde, Alfa Aesar, USA) at 4 ºC overnight, and then embedded in paraffin. Tissues Sects. (3–4 µm) were 
mounted on slides and kept at room temperature until staining. Sections were deparaffinized and stained with 
hematoxylin and eosin (H & E, Sigma-Aldrich, Oslo, Norway) and rabbit polyclonal CD68 (CD-68, Abcam, 
Cambridge, UK). Staining was imaged under a microscope as previously  described23,48.
Blood chemistry. The total cholesterol, HDL and triglyceride contents of the plasma samples were analyzed 
using an enzymatic colorimetric method (Roche, Basel, Switzerland) on the Cobas C111 system (Roche Diag-
nostics, Basal, Switzerland).
Western blot. Pulmonary arteries collected from 22 rats were used in Western blot analysis, one sample 
was missing due to technical issues. Total protein content in pulmonary arteries was quantified using the bicin-
choninic acid (BCA) protein assay kit (Thermo Scientific, Massachusetts, USA). Samples were measured at 
562 nm (PHERAstar, BMG Labtech, Ortenberg, Germany) after 30 min incubation at 37 °C. The supernatant 
was used to prepare gels while in Laemmli sample buffer containing 2% SDS. 12% Criterion Precast Gel (Bio-
Rad laboratories, Copenhagen, Denmark) was used to separate proteins, which were then electrotransferred to a 
nitrocellulose membrane. Blots were blocked with 5% nonfat dry milk in PBS-T as described  previously49. After 
washing with PBS-T, blots were incubated with primary antibodies (COX-1, COX-2 and beta-actin) overnight at 
4 °C, and visualized with horseradish peroxidase (HRP)-conjugated secondary antibodies for 1 h at room tem-
perature using the enhanced chemiluminescence system (ECL Plus, GE Healthcare, Amersham, United King-
dom). Values were normalized to total protein using Stain-Free technology.
Data analyses. GraphPad Prism software (5.02 for Windows, LaJolla, California, USA) was used for data 
analysis, similar to previous  studies34. The effects of inhibitors were calculated as a comparison of difference in 
concentration–response curves before and after administration of the drug. From these curves, –logEC50, where 
 EC50 was the concentration required to produce a half-maximal response, and maximal response were derived 
and compared using an extra sum-of-squares F test. Results are presented as means ± SEM. Differences between 
means were tested by one-way ANOVA followed by Bonferroni post hoc-test or by t-test statistics and the results 
presented as means ± SD (standard deviation of the mean). P < 0.05 was considered statistically significant.
ethical statement. Experiments were approved by Ministry of Environment and Food of Denmark for 
animal experiments, approval number 2018–15-0,201–01,477. All studies were performed in accordance with 
Animal Research: Reporting of In Vivo Experiments (ARRIVE) and the European Convention for the Protec-
tion of Vertebrate Animals used for experimental and other scientific purposes.
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